MAPT and Alzheimer disease: Blood levels of AD-implicated proteins such as neurofilament light chain (NfL), Aβ and tau (including hyperphosphorylated species) demonstrate strong concordance with CSF levels [62,63,64], thereby increasing their utility in diagnosing AD.